BLACKROCK ADVISORS LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$368,000
-22.5%
66,849
+6.7%
0.00%
Q3 2016$475,000
-3.5%
62,673
+3.8%
0.00%
Q2 2016$492,000
-37.3%
60,3550.0%0.00%
-100.0%
Q1 2016$785,000
-35.3%
60,355
-0.1%
0.00%0.0%
Q4 2015$1,213,000
+59.6%
60,413
-3.0%
0.00%0.0%
Q3 2015$760,000
-76.7%
62,282
-60.6%
0.00%
-66.7%
Q2 2015$3,263,000
+130.6%
158,011
+135.7%
0.00%
+200.0%
Q1 2015$1,415,000
+502.1%
67,039
+777.6%
0.00%
Q4 2014$235,000
+487.5%
7,639
+237.7%
0.00%
Q3 2014$40,0002,2620.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders